Pralsetinib(Gavreto)

Another Name普吉华、GAVRETO、普雷西替尼、帕拉西替尼、普雷替尼、普拉提尼

IndicationsIt is indicated for adults, adolescents and children aged 12 years and older with metastatic non-small cell lung cancer (NSCLC), as well as patients with advanced or metastatic thyroid cancer.